High-throughput measurement of human platelet aggregation under flow: application in hemostasis and beyond
SLN Brouns, JP van Geffen, JWM Heemskerk - Platelets, 2018 - Taylor & Francis
In recent years, considerable progress has been made in understanding the mechanisms
involved in platelet activation during hemostasis and thrombosis. Parallel-plate flow …
involved in platelet activation during hemostasis and thrombosis. Parallel-plate flow …
Microfluidic thrombosis under multiple shear rates and antiplatelet therapy doses
The mainstay of treatment for thrombosis, the formation of occlusive platelet aggregates that
often lead to heart attack and stroke, is antiplatelet therapy. Antiplatelet therapy dosing and …
often lead to heart attack and stroke, is antiplatelet therapy. Antiplatelet therapy dosing and …
Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay
M Lordkipanidzé, GC Lowe, NS Kirkby… - Blood, The Journal …, 2014 - ashpublications.org
Up to 1% of the population have mild bleeding disorders, but these remain poorly
characterized, particularly with regard to the roles of platelets. We have compared the …
characterized, particularly with regard to the roles of platelets. We have compared the …
[HTML][HTML] Detection of platelet sensitivity to inhibitors of COX-1, P2Y1, and P2Y12 using a whole blood microfluidic flow assay
R Li, SL Diamond - Thrombosis research, 2014 - Elsevier
Background Microfluidic devices recreate the hemodynamic conditions of thrombosis.
Methods Whole blood inhibited with PPACK was treated ex vivo with inhibitors and perfused …
Methods Whole blood inhibited with PPACK was treated ex vivo with inhibitors and perfused …
[HTML][HTML] Circulating primers enhance platelet function and induce resistance to antiplatelet therapy
TA Blair, SF Moore, I Hers - Journal of Thrombosis and Haemostasis, 2015 - Elsevier
Summary Background Aspirin and P2Y 12 antagonists are antiplatelet compounds that are
used clinically in patients with thrombosis. However, some patients are 'resistant'to …
used clinically in patients with thrombosis. However, some patients are 'resistant'to …
Administration of aspirin tablets using a novel gel-based swallowing aid: an open-label randomised controlled cross-over trial
Introduction To ease administration of medicines to people with dysphagia we developed
and patented a gel formulation within which whole tablets could be inserted. The aim was to …
and patented a gel formulation within which whole tablets could be inserted. The aim was to …
Dynamic platelet adhesion in patients with an acute coronary syndrome: the effect of antiplatelet therapy
ME Tsoumani, PT Tatsidou, IV Ntalas, JA Goudevenos… - Platelets, 2016 - Taylor & Francis
Platelet adhesion and aggregation are key functions leading to thrombus formation. The
effect of aspirin, clopidogrel, and ticagrelor on platelet aggregation has been well …
effect of aspirin, clopidogrel, and ticagrelor on platelet aggregation has been well …
Nanotopography of Polystyrene/Poly (methyl methacrylate) for the Promotion of Patient Specific Von Willebrand Factor Entrapment and Platelet Adhesion in a Whole …
Platelet function testing is essential for the diagnosis of patients with bleeding disorders.
Specifically, there is a need for a whole blood assay that is capable of analysing platelet …
Specifically, there is a need for a whole blood assay that is capable of analysing platelet …
改良型平板流动小室的研制及其在病理血管条件下血小板黏附功能检测中的应用
牛思颖, 徐嘉婕, 徐梦瑶, 张议丹, 夏利军, 江淼 - 临床输血与检验, 2022 - lcsxyjy.com
目的研制一种合适的体外模型, 用以观察病理血管条件(包括狭窄, 血流紊乱, 静脉瓣膜受损等)
下血小板在血管壁的黏附功能. 方法本研究设计了一种改良的平板流动小室装置, 以不同剪切力 …
下血小板在血管壁的黏附功能. 方法本研究设计了一种改良的平板流动小室装置, 以不同剪切力 …
Anti-platelet agents inhibit platelet adhesion and aggregation on glass surface under physiological flow conditions: Toward a microfluidic platelet functional assay …
Z Liu, X Huang, X Gao, T Zhang, C He… - Journal of …, 2022 - journals.lww.com
As the pathogenesis of arterial thrombosis often includes platelet adhesion and aggregation,
antiplatelet agents are commonly used to prevent thromboembolic events. Here, a new …
antiplatelet agents are commonly used to prevent thromboembolic events. Here, a new …